Wolkow N, Jakobiec FA, Afrogheh AH, Pai SI, et al. High Expression of PD-L1 and PD-L2 in Ophthalmic Sebaceous Carcinoma: The Case for a Clinical Trial of Checkpoint Inhibitors. Am J Ophthalmol 2020 Jul 27. pii: S0002-9394(20)30389.
PMID: 32730911